OrbiMed Israel GP II, L.P.'s Net Worth

Estimate Recalculated Nov 4, 2024 02:39AM EST

Who is OrbiMed Israel GP II, L.P.

OrbiMed Israel GP II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., LogicBio Therapeutics, Inc., 89bio, Inc., Galecto, Inc., and SteadyMed Ltd..

SEC CIK

OrbiMed Israel GP II, L.P.'s CIK is 0001682090

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adicet Bio, Inc.

Investor

Updated Jan 26, 2024

View Quote Details


Form 4	47.01%	3.13M	$2.40	$7.50M	Jan 26, 2024	11.45M	Purchase	—	Jan 25
Form 4	12.10%	875.00K	$2.09	$1.83M	Jun 29, 2023	8.32M	Purchase	—	Jun 27
Form 4	765.30%	214.28K	$14.00	$3.00M	Dec 14, 2021	7.48M	Grant	—	Dec 10
Form 4	10.25%	524.35K	$13.00	$6.82M	Feb 18, 2021	7.23M	Grant	—	Feb 12
Form 4	—	6.08M	—	—	Sep 17, 2020	6.77M	Grant	—	Sep 15 - Sep 17
Form 3	—	—	—	—	Sep 17, 2020	—	—	—	—

Showing 6 results

LogicBio Therapeutics, Inc.

Investor

Updated Oct 05, 2020


Form 4	22.91%	1.48M	$6.00	$8.89M	Oct 05, 2020	7.95M	Purchase	—	Oct 01
Form 4	-29.23%	-3.61M	$10.00	—	Oct 25, 2018	8.75M	Buy-Options	—	Oct 23
Form 3	—	—	—	—	Oct 18, 2018	—	—	—	—

Showing 3 results

89bio, Inc.

Investor

Updated Jan 27, 2022

View Quote Details


Form 4	-1.27%	-70.57K	$8.39	-$592.38K	Jan 27, 2022	5.50M	Sale	—	Jan 25 - Jan 26
Form 4	-6.87%	-275.00K	$28.00	-$7.70M	Sep 23, 2020	3.73M	Sale	—	Sep 21
Form 4	-72.55%	-12.50M	$16.00	$6.70M	Nov 13, 2019	4.73M	Buy-Options	—	Nov 11 - Nov 13
Form 3	—	—	—	—	Nov 08, 2019	611.23K	—	—	—

Showing 4 results

Galecto, Inc.

Investor

Updated Aug 17, 2023

View Quote Details


Form 4	-26.87%	-822.68K	$0.75	-$617.01K	Aug 17, 2023	2.24M	Sale	—	Aug 15
Form 4	-6.29%	-209.40K	$3.00	-$628.20K	Aug 02, 2023	3.12M	Sale	—	Jul 31
Form 4	-1.16%	-39.20K	$2.92	-$114.46K	Jul 27, 2023	3.33M	Sale	—	Jul 25
Form 4	-5.46%	-194.70K	$2.40	-$467.28K	Jul 17, 2023	3.37M	Sale	—	Jul 13
Form 4	-0.63%	-68.48K	$1.88	-$128.26K	Apr 17, 2023	10.76M	Sale	—	Apr 13 - Apr 17
Form 4	-0.61%	-67.54K	$1.81	-$121.36K	Apr 12, 2023	10.96M	Sale	—	Apr 10 - Apr 12
Form 4	-1.37%	-102.63K	$2.09	-$221.99K	Apr 07, 2023	7.41M	Sale	—	Apr 05 - Apr 06
Form 4	50.65%	2.34M	$21.06	$3.37M	Nov 04, 2020	6.96M	Purchase	—	Sep 25 - Nov 02
Form 3	—	—	—	—	Oct 28, 2020	—	—	—	—

Showing 9 results

SteadyMed Ltd.

Investor

Updated Sep 07, 2018


Form 4	-117.68%	-7.91M	$4.16	-$18.51M	Sep 07, 2018	348.50K	Sale	—	Aug 30
Form 4	57.32%	1.76M	$3.02	$7.00M	Apr 27, 2017	4.83M	Purchase	—	Apr 25
Form 3	—	—	—	—	Aug 12, 2016	3.07M	—	—	—

Showing 3 results

Upstream Bio, Inc.

Investor

Updated Oct 17, 2024

View Quote Details


Form 4	16.95%	825.00K	$17.00	—	Oct 17, 2024	5.69M	Purchase	—	Oct 15
Form 3	—	—	—	—	Oct 10, 2024	1.26M	—	—	—

Showing 2 results